KCS Wealth Advisory purchased a new position in Humana Inc (NYSE:HUM) in the 4th quarter, Holdings Channel reports. The fund purchased 1,073 shares of the insurance provider’s stock, valued at approximately $266,000.
Other institutional investors have also recently added to or reduced their stakes in the company. WFG Advisors LP lifted its position in shares of Humana by 4.5% during the 2nd quarter. WFG Advisors LP now owns 469 shares of the insurance provider’s stock worth $113,000 after purchasing an additional 20 shares during the last quarter. Fieldpoint Private Securities LLC purchased a new stake in shares of Humana during the 3rd quarter worth $115,000. Acrospire Investment Management LLC purchased a new stake in shares of Humana during the 2nd quarter worth $120,000. Northwestern Mutual Wealth Management Co. lifted its position in shares of Humana by 139.5% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 558 shares of the insurance provider’s stock worth $134,000 after purchasing an additional 325 shares during the last quarter. Finally, ClariVest Asset Management LLC purchased a new stake in shares of Humana during the 3rd quarter worth $144,000. 94.01% of the stock is owned by institutional investors and hedge funds.
In other news, VP Timothy S. Huval sold 1,382 shares of the company’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total value of $340,027.28. Following the completion of the sale, the vice president now directly owns 11,557 shares of the company’s stock, valued at $2,843,484.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Brian P. Leclaire sold 1,679 shares of the company’s stock in a transaction dated Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the completion of the sale, the senior vice president now directly owns 9,888 shares of the company’s stock, valued at $2,432,151.36. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,115 shares of company stock valued at $2,501,627. 0.80% of the stock is owned by corporate insiders.
Shares of Humana Inc (NYSE HUM) opened at $268.02 on Friday. Humana Inc has a 1 year low of $186.25 and a 1 year high of $271.99. The firm has a market cap of $38,289.34, a price-to-earnings ratio of 22.87, a P/E/G ratio of 1.74 and a beta of 0.88. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 0.35.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating analysts’ consensus estimates of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The firm had revenue of $13.28 billion during the quarter, compared to analysts’ expectations of $13.41 billion. During the same period in the previous year, the company earned $3.18 earnings per share. Humana’s quarterly revenue was down 3.0% compared to the same quarter last year. equities analysts predict that Humana Inc will post 11.63 EPS for the current year.
Humana announced that its Board of Directors has approved a share repurchase plan on Thursday, December 14th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the insurance provider to repurchase shares of its stock through open market purchases. Shares repurchase plans are typically a sign that the company’s board believes its shares are undervalued.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Friday, December 29th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a yield of 0.60%. Humana’s dividend payout ratio (DPR) is presently 12.59%.
Several equities research analysts have recently issued reports on HUM shares. Credit Suisse Group decreased their price objective on shares of Humana from $256.00 to $246.00 and set a “neutral” rating for the company in a research report on Friday, November 10th. ValuEngine cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. BMO Capital Markets started coverage on shares of Humana in a research report on Monday, October 16th. They set an “outperform” rating and a $300.00 price objective for the company. Goldman Sachs Group started coverage on shares of Humana in a research report on Wednesday, January 3rd. They set a “buy” rating and a $305.00 price objective for the company. Finally, Zacks Investment Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Ten analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $258.90.
TRADEMARK VIOLATION NOTICE: “1,073 Shares in Humana Inc (HUM) Acquired by KCS Wealth Advisory” was originally reported by Stock Observer and is owned by of Stock Observer. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://www.thestockobserver.com/2018/01/14/1073-shares-in-humana-inc-hum-acquired-by-kcs-wealth-advisory.html.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.